Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,019
datasets available to search
ShareScore release 0.9.0
Dataset results
2,019 results for “pediatric patients”
Dataset of EEG recordings of pediatric patients with epilepsy based on the 10-20 system
Open the record for dataset details and reuse information.
Longitudinal observational study of pediatric patients with primary brain tumors: establishment of a hospital-based registry.
<p>Although tumors of the central nervous system (CNS) represent 2 % of all malignancies in general, they cause a disproportionately large morbidity and mortality and are the second most common form of cancer in children and the major solid tumor in childhood in the U.S., occurring in 21.3% of all children with malignant disease. The treatment of brain tumors in children and adolescents has evolved significantly in recent decades. Nowadays, most children with a diagnosis of brain tumor are treated properly and achieve prolonged survival. In order to obtain an overview of the impact of brain tumors, specialized registries, which provide information on all types of brain tumors, have emerged in several countries. Following on the pioneering Japanese and American experiences of specialized national records of brain tumors, other specialized registries were opened in European countries. This project aims to initiate a registry of the epidemiological profile of patients treated for CNS tumors in the Pediatric Cancer Center (CPC) of our hospital from January 2000 to December 2013, at diagnosis and during follow-up, updating information periodically. This data will be recorded in an electronic database capable of storing, retrieving and presenting information of interest. Prospectively recorded epidemiological data of patients diagnosed from January 2014 will be accrued, maintaining the database active to continuously record information on patients with CNS tumors treated in the CPC HIAS. Thus, creating a hospital registry of pediatric patients with CNS tumors. To this end, an instrument of data collection will be created using Google Apps (Google Inc., 2014), a digital platform with capacity for storage, creation and editing of documents and collaboration in real time over the cloud.</p>
The Supplementary Material for the article entitled "Comparative analysis of global transcriptomes in nontyphoidal Salmonella clinical isolates from pediatric patients with and without bacteremia after infecting human intestinal epithelium in vitro"
<p>The Supplementary Material (Additional files 1-5, including Table S1-S4 and Figure S1) for this article.</p> <p> </p> <p><strong>Table S1.</strong> Upregulated genes in Group B versus Groups A and C+D.</p> <p> </p> <p><strong>Table S2.</strong> Downregulated genes in Group B versus Groups A and C+D.</p> <p> </p> <p><strong>Table S3. </strong>The enriched GO terms in Group B versus Groups A and C+D.</p> <p> </p> <p><strong>Table S4. </strong>The enriched KEGG pathways in Group B versus Groups A and C+D.</p> <p> </p> <p><strong>Figure S1. </strong>The enriched GO terms and KEGG pathways in Group B relative to Group A. Bar charts show the enriched GO terms (A) and the enriched KEGG pathways (B) by significance power. Color of bars indicate power of significance and length in x axes of bar indicate number of annotated genes in the particular term of pathway. Cnetplots show the relationship between GO term (C) and KEGG pathways (D). Dot size representing GO terms and KEGG pathways indicates number of significantly changed and its annotated genes. The GO terms or KEGG pathways connected through their common and annotated genes. </p>
Dataset from: "Assessment of depression, anxiety, and psychological symptoms in parents of pediatric palliative care patients: A single-center case-control study"
<p>The dataset comprises raw data from a case-control study that compared levels of depression, anxiety, and general psychological symptoms between parents of pediatric palliative care (PPC) patients and parents of healthy controls.</p> <p>Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Symptom Checklist-90 Revised (SCL-90-R) were employed to provide a comprehensive and nuanced understanding of the mental health challenges faced by parents.</p> <p>The designation "case" in the first column (A) represents the parents of PPC patients, while the designation "control" represents the control group. The columns labeled B to S present demographic characteristics data, while columns T to AR present inventory scores. Columns BB to GC, in turn, present the responses to the inventory items.</p> <p> </p> <p> </p>
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
ClinicalTrials.gov study NCT02228096. IPD Sharing: YES. Countries: 1. Publications: 4.
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
ClinicalTrials.gov study NCT03474965. IPD Sharing: YES. Countries: 14. Publications: 1.
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
ClinicalTrials.gov study NCT03610724. IPD Sharing: YES. Countries: 14. Publications: 1.
Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
ClinicalTrials.gov study NCT03569475. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT01892722. IPD Sharing: UNDECIDED. Countries: 25. Publications: 2.
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT04718870. IPD Sharing: YES. Countries: 2. Publications: 0.
Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency
ClinicalTrials.gov study NCT02292654. IPD Sharing: YES. Countries: 6. Publications: 1.
Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease
ClinicalTrials.gov study NCT03491215. IPD Sharing: YES. Countries: 8. Publications: 1.
Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)
ClinicalTrials.gov study NCT05089656. IPD Sharing: YES. Countries: 13. Publications: 1.
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.
ClinicalTrials.gov study NCT01844765. IPD Sharing: YES. Countries: 13. Publications: 3.
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Fai
ClinicalTrials.gov study NCT02678312. IPD Sharing: YES. Countries: 29. Publications: 2.
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
ClinicalTrials.gov study NCT02684058. IPD Sharing: YES. Countries: 20. Publications: 4.
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
ClinicalTrials.gov study NCT03793608. IPD Sharing: YES. Countries: 2. Publications: 2.
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
ClinicalTrials.gov study NCT04851873. IPD Sharing: YES. Countries: 9. Publications: 1.
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
ClinicalTrials.gov study NCT02798471. IPD Sharing: YES. Countries: 34. Publications: 1.
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involveme
ClinicalTrials.gov study NCT00920647. IPD Sharing: YES. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.